이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

치료받지 않은 맨틀 세포 림프종 환자에서 자누브루티닙 + 리투시맙 대 벤다무스틴 + 리툭시맙 비교 연구 (MANGROVE)

2026년 9월 25일 업데이트: BeOne Medicines

줄기 세포 이식에 부적격한 이전에 치료받지 않은 맨틀 세포 림프종 환자에서 Zanubrutinib(BGB-3111) + Rituximab 대 Bendamustine + Rituximab을 비교하는 3상 무작위, 공개, 다기관 연구

This is a randomized study to compare the efficacy and safety of zanubrutinib plus rituximab versus bendamustine plus rituximab in previously untreated participants with mantle cell lymphoma (MCL) who are not eligible for stem cell transplantation.

연구 개요

상태

모집하지 않고 적극적으로

정황

개입 / 치료

상세 설명

Our company, previously known as BeiGene, is now officially BeOne Medicines. Because some of our older studies were sponsored under the name BeiGene, you may see both names used for this study on this website.

연구 유형

중재적

등록 (실제)

510

단계

  • 3단계

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 장소

      • Goes, 네덜란드, 4462 RA
        • Admiraal de Ruijter Ziekenhuis
      • Groningen, 네덜란드, 9713 GZ
        • University of Medical Center Groningen (Umcg)
      • Nieuwegein, 네덜란드, 3435 CM
        • St Antonius Ziekenhuis, Randd Interne Geneeskunde (F)
      • Nijmegen, 네덜란드, 6525 GA
        • Albert Schweitzer Ziekenhuis
      • Rotterdam, 네덜란드, 3015 GD
        • Erasmus Mc
      • The Hague, 네덜란드, 2545 CH
        • Hagaziekenhuis
      • Christchurch, 뉴질랜드, 8011
        • Christchurch Hospital (Canterbury Health Laboratories)
      • Tauranga, 뉴질랜드, 3112
        • Tauranga Hospital
      • Tainan, 대만, 704
        • National Cheng Kung University Hospital
      • Tainan, 대만, 736
        • Chi Mei Hospital Liouying
      • Taipei, 대만, 114
        • Tri Service General Hospital
      • Cologne, 독일, 50937
        • Uniklinik Koln (Aor)
      • Heidelberg, 독일, 69120
        • Universitatsklinikum Heidelberg
      • Munich, 독일, 81377
        • Dept of Medicine Iii, University Hospitallmu
      • Ulm, 독일, 89081
        • Universitaetsklinikum Ulm, Innere Medizin Iii
      • Wuppertal, 독일, 42283
        • Petrus Krankenhaus Wuppertal
      • Moscow, 러시아 제국, 142770
        • Gbuz Mmcc Kommunarka Dzm
    • Moscow
      • Moscow, Moscow, 러시아 제국, 125284
        • Clinical Hospital, Sp Botkin
    • Sankt-Peterburg
      • Saint Petersburg, Sankt-Peterburg, 러시아 제국, 191024
        • Fgu Russian Scientific Research Institute of Hematology and Transfusiology
      • Saint Petersburg, Sankt-Peterburg, 러시아 제국, 194291
        • Leningrad Regional Clinic and Hospital
      • Bucharest, 루마니아, 022328
        • Institutul Clinic Fundeni
      • Iași, 루마니아, 700483
        • Institutul Regional de Oncologie Iasi
    • California
      • Orange, California, 미국, 92868
        • Chao Family Comprehensive Cancer Center
    • Illinois
      • Chicago, Illinois, 미국, 60612
        • Rush University Medical Center
    • Massachusetts
      • Boston, Massachusetts, 미국, 02215-5400
        • Beth Israel Deaconess Medical Center (Bidmc)
    • Michigan
      • Ann Arbor, Michigan, 미국, 48109
        • University of Michigan Health System
    • Nevada
      • Las Vegas, Nevada, 미국, 89169
        • Comprehensive Cancer Centers of Nevada
    • New York
      • New York, New York, 미국, 10029
        • Icahn School of Medicine At Mount Sinai
      • Westbury, New York, 미국, 11590
        • Clinical Research Alliance, Inc
    • Oregon
      • Portland, Oregon, 미국, 97213
        • Providence Portland Medical Center
    • Pennsylvania
      • Pittsburgh, Pennsylvania, 미국, 15224
        • West Penn Hospital
    • Texas
      • Houston, Texas, 미국, 77030-4009
        • The University of Texas Md Anderson Cancer Center
      • Lubbock, Texas, 미국, 79410
        • Joe Arrington Cancer Research and Treatment Center
    • Washington
      • Seattle, Washington, 미국, 98109
        • Seattle Cancer Care Alliance
      • Bruges, 벨기에, 8000
        • Az Sint Jan Brugge
      • Brussels, 벨기에, 1090
        • Universitair Ziekenhuis Brussel
      • Edegem, 벨기에, 2650
        • Uz Antwerpen
      • Kortrijk, 벨기에, 8500
        • Az Groeninge Campus Loofstraat
      • Liège, 벨기에, 4000
        • Centre Hospitalier Universitaire (Chu) de Liege Site Du Sart Tilman
      • Yvoir, 벨기에, 5530
        • Centre Hospitalier Universitaire Universite Catholique de Louvain Site Godinne
      • Barcelona, 스페인, 08035
        • Hospital Universitario Vall Dhebron
      • Barcelona, 스페인, 08916
        • Ico Hug Trias I Pujol
      • Barcelona, 스페인, 08908
        • Institut Catala Doncologia
      • Girona, 스페인, 17007
        • Ico Girona
      • Madrid, 스페인, 28046
        • Hospital Universitario La Paz
      • Madrid, 스페인, 28040
        • Start Madrid Fundacion Jimenez Diaz
      • Madrid, 스페인, 28033
        • Md Anderson Cancer Center Madrid Spain
      • Madrid, 스페인, 28009
        • Hospital Universitario Gregorio Maranon
      • Málaga, 스페인, 29010
        • Hospital Regional Universitario de Malaga
      • Seville, 스페인, 41013
        • Hospital Universitario Virgen Del Rocio
      • Cork, 아일랜드, t12DC4A
        • Cork University Hospital
      • Dublin, 아일랜드, D7
        • Mater Misericordiae University Hospital
      • Dublin, 아일랜드, D8
        • St Jamess Hospital
      • Galway, 아일랜드, H91 YR71
        • University Hospital Galway
      • Limerick, 아일랜드, V94F858
        • University Hospital Limerick
      • Waterford, 아일랜드, X91 ER8E
        • University Hospital Waterford
      • Abergavenny, 영국, NP7 7EG
        • Aneurin Bevan University Health Board
      • Birmingham, 영국, B9 5SS
        • Birmingham Heartlands Hospital
      • Dudley, 영국, DY1 2HQ
        • Russells Hall Hopsital
      • Sutton, 영국, SM2 5PT
        • Royal Marsden Nhs Foundation Royal Marsden Hospital
      • Linz, 오스트리아, 4020
        • Ordensklinikum Linz Gmbh Elisabethinen
      • Salzburg, 오스트리아, 5020
        • Universitatsklinik Fur Innere Medizin Iii Universitatsklinikum Der Pmu Landeskrankenhaus Salzburg
      • Vienna, 오스트리아, 1090
        • Medical University Vienna Oncology
      • Cherkasy, 우크라이나, 18009
        • Cherkasy Regional Oncology Dispensary
      • Dnipro, 우크라이나, 49102
        • Municipal Non Profit Enterprise City Clinical Hospital
      • Kiev, 우크라이나, 3022
        • National Cancer Institute
      • Lviv, 우크라이나, 79044
        • Si Institute of Blood Pathology and Transfusion Medicine Nams of Ukraine, Hematology Department
      • Alessandria, 이탈리아, 15121
        • Azienda Ospedaliera Nazionale Ssantonio E Biagio E Cesare Arrigo
      • Bologna, 이탈리아, 40138
        • Policlinico Sorsola Malpighi, Aou Di Bologna
      • Genova, 이탈리아, 16132
        • Azienda Ospedaliera Universitaria San Martino
      • Milan, 이탈리아, 20162
        • Niguarda Cancer Center Division of Hematology
      • Novara, 이탈리아, 28100
        • Aou Maggiore Della Carita
      • Palermo, 이탈리아, 90146
        • Aoor Villa Sofia Cervello
      • Pisa, 이탈리아, 56126
        • Aou Pisana, Stabilimento Di Santa Chiara
      • Ravenna, 이탈리아, 48121
        • Unita Di Ematologia, Dipartimento Di Ematologia Ed Oncologia
      • Reggio Emilia, 이탈리아, 42123
        • Azienda Unita Sanitaria Locale Irccs
      • Roma, 이탈리아, 00161
        • Universita Degli Studi La Sapienza
      • Siena, 이탈리아, 53100
        • Aou Senese Policlinico Santa Maria Alle Scotte
      • Torino, 이탈리아, 10126
        • Ao Citta Della Salute E Della Scienza Di Torino Presidio O
      • Verona, 이탈리아, 37142
        • University of Verona
      • Yokohama, 일본, 221-0855
        • Yokohama Municipal Citizens Hospital
    • Aichi-ken
      • Nagoya, Aichi-ken, 일본, 460-0001
        • National Hospital Organization Nagoya Medical Center
      • Toyohashi, Aichi-ken, 일본, 441-8570
        • Toyohashi Municipal Hospital
    • Chiba
      • Chiba, Chiba, 일본, 260-8717
        • Chiba Cancer Center
    • Fukuoka
      • Kurume, Fukuoka, 일본, 830-0011
        • Kurume University Hospital
    • Hiroshima
      • Hiroshima, Hiroshima, 일본, 730-8619
        • Hiroshima Red Cross Hospital and Atomic Bomb Survivors Hospital
    • Kanagawa
      • Yokohama, Kanagawa, 일본, 241-8515
        • Kanagawa Cancer Center
    • Kumamoto
      • Kumamoto, Kumamoto, 일본, 860-0008
        • National Hospital Organization Kumamoto Medical Center
    • Kyoto
      • Kyoto, Kyoto, 일본, 602-8566
        • University Hospital, Kyoto Prefectural Univ of Medicine
    • Miyagi
      • Sendai, Miyagi, 일본, 980-8574
        • Tohoku University Hospital
    • Okayama-ken
      • Kurashikishi, Okayama-ken, 일본, 710-8602
        • Kurashiki Central Hospital
      • Okayama, Okayama-ken, 일본, 701-1192
        • National Hospital Organization Okayama Medical Center
    • Osaka
      • Osaka, Osaka, 일본, 545-8586
        • Osaka Metropolitan University Hospital
      • Osakashi, Osaka, 일본, 543-8555
        • Osaka Red Cross Hospital
    • Tokyo
      • Chuoku, Tokyo, 일본, 104-0045
        • National Cancer Center Hospital
      • Tokyo, Tokyo, 일본, 113-8519
        • Tokyo Medical and Dental University Hospital
    • Beijing Municipality
      • Beijing, Beijing Municipality, 중국, 100044
        • Peking University Peoples Hospital
      • Beijing, Beijing Municipality, 중국, 100050
        • Beijing Friendship Hospital, Capital Medical University
    • Fujian
      • Fuzhou, Fujian, 중국, 350001
        • Fujian Medical University Union Hospital
      • Quanzhou, Fujian, 중국, 362000
        • Quanzhou First Affliated Hospital of Fujian Medical University
    • Guangdong
      • Guangzhou, Guangdong, 중국, 510080
        • Guangdong Provincial Peoples Hospital
      • Guangzhou, Guangdong, 중국, 510515
        • Nanfang Hospital of Southern Medical University
      • Guangzhou, Guangdong, 중국, 510060
        • Sun Yat Sen University Cancer Center
    • Heilongjiang
      • Harbin, Heilongjiang, 중국, 150000
        • Harbin Medical University Cancer Hospital
    • Henan
      • Zhengzhou, Henan, 중국, 450000
        • Henan Cancer Hospital
    • Hubei
      • Wuhan, Hubei, 중국, 430030
        • Tongji Hospital of Tongji Medical College Huazhong University of Science and Technology
    • Hunan
      • Changsha, Hunan, 중국, 410013
        • Hunan Cancer Hospital
    • Jiangsu
      • Nanjing, Jiangsu, 중국, 210029
        • Jiangsu Province Hospital
      • Nanjing, Jiangsu, 중국, 210008
        • Nanjing Drum Tower Hospital,the Affiliated Hospital of Nanjing University Medical School
      • Xuzhou, Jiangsu, 중국, 221000
        • The Affiliated Hospital of Xuzhou Medical University
    • Jiangxi
      • Nanchang, Jiangxi, 중국, 330006
        • The First Affiliated Hospital of Nanchang University Branch Donghu
    • Jilin
      • Changchun, Jilin, 중국, 130021
        • The First Hospital of Jilin University
      • Changchun, Jilin, 중국, 130021
        • Jilin Cancer Hospital
    • Liaoning
      • Shenyang, Liaoning, 중국, 110004
        • Shengjing Hospital of China Medical University
    • Shanghai Municipality
      • Shanghai, Shanghai Municipality, 중국, 200000
        • Fudan University Shanghai Cancer Center
      • Shanghai, Shanghai Municipality, 중국, 200120
        • Shanghai East Hospital
    • Sichuan
      • Chengdu, Sichuan, 중국, 610041
        • West China Hospital, Sichuan University
    • Tianjin Municipality
      • Tianjin, Tianjin Municipality, 중국, 300060
        • Tianjin Medical University Cancer Institute and Hospital
      • Tianjin, Tianjin Municipality, 중국, 300020
        • Institute of Hematology and Hospital of Blood Disease
    • Xinjiang
      • Ürümqi, Xinjiang, 중국, 830000
        • Affiliated Cancer Hospital of Xinjiang Medical University
    • Zhejiang
      • Hangzhou, Zhejiang, 중국, 310022
        • Zhejiang Cancer Hospital
      • Hangzhou, Zhejiang, 중국, 310003
        • The First Affiliated Hospital, Zhejiang University School of Medicine
      • Ningbo, Zhejiang, 중국, 315000
        • Hwa Mei Hospital, University of Chinese Academy of Sciences (Ningbo No Hospital)
    • Ontario
      • Ottawa, Ontario, 캐나다, K1H 8M2
        • The Ottawa Hospital
    • Quebec
      • Sherbrooke, Quebec, 캐나다, J1H 5N4
        • Ciusss de Lestrie Chus
      • Ankara, 터키 (Türkiye), 06620
        • Dr Abdurrahman Yurtaslan Oncology Teaching and Research Hospital
      • Ankara, 터키 (Türkiye), 6500
        • Gazi University
      • Ankara, 터키 (Türkiye), 06700
        • Hematoloji Ve Hematolik Onkoloji Tani Ve Tedavi Merezi
      • Edirne, 터키 (Türkiye), 22030
        • Tr Trakya University Health Research and Application Center (Hospital)
      • Istanbul, 터키 (Türkiye), 34365
        • Vkv American Hospital
      • Mersin, 터키 (Türkiye), 33000
        • Mersin Universitesi Tip Fakultesi Hastanesi
      • Lisbon, 포르투갈, 1099-023
        • Instituto Portugues Oncologia de Lisboa Francisco Gentil, Epe
      • Lisbon, 포르투갈, 1649-035
        • Chuln Hospital de Santa Maria
      • Porto, 포르투갈, 4099-001
        • Centro Hospitalar Universitario Porto
      • Porto, 포르투갈, 4200-072
        • Instituto Portugues de Oncologia Do Porto Francisco Gentil, Epe
      • Bydgoszcz, 폴란드, 85-168
        • Szpital Uniwersytecki Nr Im Dr Jana Biziela
      • Chorzów, 폴란드, 41-503
        • Silesian Healthy Blood Clinic
      • Gdansk, 폴란드, 80-952
        • Uniwersyteckie Centrum Kliniczne
      • Gdask, 폴란드, 80-219
        • Copernicus Podmiot Leczniczy Sp Z Oo Wojewodzkie Centrum Onkologii
      • Gdynia, 폴란드, 81-519
        • Szpitale Pomorskie Spolka Z Ograniczona Odpowiedzialnoscia
      • Krakow, 폴란드, 30-727
        • Pratia McM Krakow
      • Legnica, 폴란드, 59-220
        • Wojewodzki Szpital Specjalistyczny W Legnicy
      • Lodz, 폴란드, 93-510
        • Wielospecjalistyczne Centrum Onkologii I Traumatologii Im M Kopernika W Lodzi
      • Lublin, 폴란드, 20-090
        • Centrum Onkologii Ziemi Lubelskiej
      • Warsaw, 폴란드, 02-776
        • Instytut Hematologii I Transfuzjologii W Warszawie
      • Wałbrzych, 폴란드, 58-309
        • Specjalistyczny Szpital Im Dr Alfreda Sokolowskiego
      • Wroclaw, 폴란드, 50-556
        • Uniwersytecki Szpital Kliniczny Im Jana Mikulicza Radeckiego We Wroclawiu
      • Bordeaux, 프랑스, 33076
        • Centre de Lutte Contre Le Cancer Institut Bergonie
      • Brest, 프랑스, 29200
        • Chru de Brest Hospital Morvan
      • Dijon, 프랑스, J4V 2H1
        • Chu Dijon
      • Grenoble, 프랑스, 38043
        • Chu Grenoble Alpes
      • Le Mans, 프랑스, 72037
        • Centre Hospitalier Le Mans
      • Lille, 프랑스, 59000
        • Hopital Claude Huriez Chu Lille
      • Marseille, 프랑스, 13009
        • Institut Paoli Calmettes
      • Nantes, 프랑스, 44093
        • Centre Hospitalier Universitaire Nantes Hotel Dieu
      • Paris, 프랑스, 75005
        • Institut Curie
      • Paris, 프랑스, 75015
        • Necker University Hospital
      • PierreBenite, 프랑스, 69495
        • Chu Hopital Lyon Sud
      • Poitiers, 프랑스, 86000
        • Centre Hospitalier Universitaire de Poitier Hopital de La Miletrie Hopital Jean Bernard
      • Quimper, 프랑스, 29000
        • Ch Cornouaille
      • Toulouse, 프랑스, 31059
        • Iuc Toulouse Oncopole
    • Australian Capital Territory
      • Garran, Australian Capital Territory, 호주, 2605
        • Canberra Hospital
    • New South Wales
      • Concord, New South Wales, 호주, 2139
        • Concord Repatriation General Hospital
      • Cudgen, New South Wales, 호주, 2487
        • The Tweed Valley Hospital
      • Darlinghurst, New South Wales, 호주, 2010
        • Saint Vincents Hospital Sydney
      • Gosford, New South Wales, 호주, 2250
        • Gosford Hospital
      • Waratah, New South Wales, 호주, 2298
        • Calvary Mater Newcastle
    • Queensland
      • Birtinya, Queensland, 호주, 4575
        • Sunshine Coast Hospital and Health Service
      • South Brisbane, Queensland, 호주, 4101
        • Icon Cancer Foundation
    • South Australia
      • Bedford PK, South Australia, 호주, 5042
        • Flinders Medical Centre
    • Tasmania
      • Hobart, Tasmania, 호주, 7000
        • Royal Hobart Hospital
    • Victoria
      • Clayton, Victoria, 호주, 3168
        • Monash Health
      • Fitzroy, Victoria, 호주, 3065
        • St Vincents Hospital Melbourne
      • Frankston, Victoria, 호주, 3199
        • Peninsula Private Hospital
      • Geelong, Victoria, 호주, 3220
        • Barwon Health the Geelong Hospital
    • Western Australia
      • Perth, Western Australia, 호주, 6000
        • Royal Perth Hospital

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

60년 이상 (성인, 고령자)

건강한 자원 봉사자를 받아들입니다

아니

연구 대상 성별

모두

설명

Key Inclusion Criteria:

  1. ≥70 years of age at the time of informed consent, OR ≥60 and <70 years of age with comorbidities precluding autologous stem cell transplantation
  2. Histologically confirmed diagnosis of MCL
  3. No prior systemic treatments for MCL
  4. Measurable disease by CT/MRI
  5. Eastern Cooperative Oncology Group (ECOG) performance status of 0-2
  6. Adequate marrow and organ function

Key Exclusion Criteria:

  1. Known central nervous system involvement by lymphoma
  2. Participants for whom the goal of therapy is tumor debulking prior to stem cell transplant
  3. Clinically significant cardiovascular disease
  4. History of severe bleeding disorder
  5. Unable to swallow capsules or disease significantly affecting gastrointestinal function
  6. Active fungal, bacterial and/or viral infection requiring systemic therapy
  7. Requires ongoing treatment with a strong CYP3A inhibitor or inducer

NOTE: Other protocol defined Inclusion/Exclusion criteria may apply.

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 치료
  • 할당: 무작위
  • 중재 모델: 병렬 할당
  • 마스킹: 없음(오픈 라벨)

무기와 개입

참가자 그룹 / 팔
개입 / 치료
실험적: Arm A: zanubrutinib plus rituximab

Participants will receive zanubrutinib plus rituximab, followed by zanubrutinib monotherapy until Independent Review Committee (IRC)-confirmed disease progression.

Administered as two 80 mg capsules by mouth twice a day

다른 이름들:
  • 브루킨사
  • BGB-3111

Administered intravenously at a dose of 375 mg/m2 on Day 1 of Cycles 1 to 6

활성 비교기: Arm B: bendamustine plus rituximab

Participants will receive bendamustine plus rituximab, followed by observation.

Administered intravenously at a dose of 375 mg/m2 on Day 1 of Cycles 1 to 6

Administered intravenously at a dose of 90 mg/m2/day on Days 1 and 2 of Cycles 1 to 6

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Progression-free survival (PFS) determined by independent central review
기간: Up to approximately 7 years

PFS is defined as the time from randomization to the date of first documentation of disease progression or death, whichever occurs first.

Up to approximately 7 years

2차 결과 측정

결과 측정
측정값 설명
기간
PFS by investigator assessment
기간: Up to approximately 7 years

PFS is defined as the time from randomization to the date of first documentation of disease progression or death, whichever occurs first.

Up to approximately 7 years
Overall response rate (ORR)
기간: Up to approximately 7 years

ORR is defined as the percentage of participants who achieve a complete response (CR) or partial response (PR), determined by independent central review and by investigator assessment.

Up to approximately 7 years
Duration of response (DOR)
기간: Up to approximately 7 years

DOR, as determined by independent central review and by investigator assessment, and defined as the time from the date that response criteria are first met to the date that disease progression is objectively documented or death, whichever occurs first.

Up to approximately 7 years
Overall survival (OS)
기간: Up to approximately 7 years

OS is defined as the time from randomization to the date of death due to any reason.

Up to approximately 7 years
Time to Response (TTR)
기간: Up to approximately 7 years

TTR, as determined by independent central review and by investigator assessment, and defined as the time from randomization to the first documentation of response.

Up to approximately 7 years
Rate of complete response (CR) or complete metabolic response
기간: Up to approximately 7 years

Rate of CR or complete metabolic response is defined as the percentage of participants who achieve a CR or complete metabolic response, determined by independent central review and by investigator assessment.

Up to approximately 7 years
Participant-reported outcomes (PROs) as assessed by the European Quality of Life 5-Dimension 5 Level Questionnaire (EQ-5D-5L)
기간: Up to approximately 7 years

EuroQoL-Five Dimensions, Five Levels (EQ-5D-5L) is a generic, self-reported measure of utility that consists of a five-item descriptive system and a visual analogue scale (EQ VAS). The descriptive system involves five health dimensions (mobility, self-care, usual activities, pain/discomfort and anxiety/depression). Participants may choose from the following response levels: no problems=1; slight problems=2; moderate problems=3; severe problems=4; and unable to/extreme problems=5. Higher values indicate worst health.

Up to approximately 7 years
PROs as assessed by the European Organization for Research on Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30)
기간: Up to approximately 7 years

The EORTC QLQ-30 contains 30 questions that incorporate 5 functional scales (physical functioning, role functioning, emotional functioning, cognitive functioning, and social functioning), 1 global health status scale, 3 symptom scales (fatigue, nausea and vomiting, and pain), and 6 single items (dyspnea, insomnia, appetite loss, constipation, diarrhea, and financial difficulties). The participant answers questions about their health during the past week. There are 28 questions answered on a 4-point scale where 1 =Not at all (best) to 4 =Very Much (worst) and 2 questions answered on a 7-point scale where 1 =Very poor (worst) to 7 =Excellent (best).

Up to approximately 7 years
Number of participants with adverse events and serious adverse events
기간: Up to approximately 7 years

Number of participants with adverse events and serious adverse events, including laboratory values, vital signs, and physical examination findings.

Up to approximately 7 years

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

스폰서

수사관

  • 연구 책임자: Study Director, BeOne Medicines

간행물 및 유용한 링크

연구에 대한 정보 입력을 담당하는 사람이 자발적으로 이러한 간행물을 제공합니다. 이것은 연구와 관련된 모든 것에 관한 것일 수 있습니다.

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (실제)

2019년 8월 20일

기본 완료 (실제)

2026년 4월 27일

연구 완료 (추정된)

2031년 9월 30일

연구 등록 날짜

최초 제출

2019년 6월 27일

QC 기준을 충족하는 최초 제출

2019년 6월 27일

처음 게시됨 (실제)

2019년 6월 28일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 9월 30일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 9월 25일

마지막으로 확인됨

2026년 9월 1일

추가 정보

이 연구와 관련된 용어

키워드

기타 연구 ID 번호

  • BGB-3111-306
  • 2019-000413-36 (EudraCT 번호)
  • CTR20211594 (레지스트리 식별자: ChinaDrugTrials)
  • 2023-509908-15-00 (씨티스)
  • 2023 (미국 NIH 보조금/계약)
  • 2019 (미국 NIH 보조금/계약)

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

예

IPD 계획 설명

BeOne shares data on completed studies responsibly and provides qualified scientific and medical researchers access to data and supporting documentation for clinical trials in dossiers for medicines and indications after submission and approval in the United States, China, and Europe. Clinical trials supporting subsequent local approvals, new indications, or combination products are eligible for sharing once corresponding regulatory approvals are achieved.

BeOne shares data only when permitted by applicable data privacy and security laws and regulations, when it is feasible to do so without compromising the privacy of study participants, and other considerations.

Qualified researchers with appropriate competencies who are engaged in novel scientific research may submit a request for participant-level data with a research proposal for BeOne review. Research teams must include a biostatistician and sign a Data Sharing Agreement prior to receiving access to clinical trial data.

IPD 공유 기간

See plan description

IPD 공유 액세스 기준

See plan description

IPD 공유 지원 정보 유형

  • 연구_프로토콜
  • 수액
  • CSR

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

예

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .